Brisson, M., Brodeur, C., Létourneau‐Guillon, L., Masellis, M., Stoessl, J., Tamm, A., . . . Soucy, J. (2021). CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment. Alzheimers Dement (N Y).
Παραπομπή Chicago StyleBrisson, Mélanie, et al. "CCCDTD5: Clinical Role of Neuroimaging and Liquid Biomarkers in Patients With Cognitive Impairment." Alzheimers Dement (N Y) 2021.
Παραπομπή MLABrisson, Mélanie, et al. "CCCDTD5: Clinical Role of Neuroimaging and Liquid Biomarkers in Patients With Cognitive Impairment." Alzheimers Dement (N Y) 2021.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.